Mivebresib
Mivebresib is a potent BET inhibitor with potential antineoplastic activity. It disrupts critical transcription programs that drive prostate cancer growth to induce potent anti-tumor activity in vitro and in vivo.
Product Specifications
Shipping Conditions
Gel Pack
Storage Conditions
-20°C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
039976 200 µL
PI16, ID (PI16, CRISP9, PSPBP, Peptidase inhibitor 16, Cysteine-rich secretory protein 9, PSP94-binding protein)
Sign In for Pricing
View Details 
TA503955 100 µL
Kv beta 1 (KCNAB1) Mouse Monoclonal Antibody [Clone ID: OTI1C2]
Sign In for Pricing
View Details MBS143655-01 0.05 mg
Recombinant Ovine Leptin Triple Antagonist, Pegylated
Sign In for Pricing
View Details